Institutional investors purchased a net $16.2 thousand shares of ICCC during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 12.46% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERRITT CAPITAL MANAGEMENT, INC. Bought 20.5 Thousand shares of ImmuCell Corp
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 16.6 Thousand shares of ImmuCell Corp
RBF CAPITAL LLC Bought 13.1 Thousand shares of ImmuCell Corp